You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Woodward Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for WOODWARD, and what generic and branded alternatives to WOODWARD drugs are available?

WOODWARD has seven approved drugs.

Summary for Woodward

US Patents:	0
Tradenames:	8
Ingredients:	6
NDAs:	7

Drugs and US Patents for Woodward

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Woodward Specl	DECA-DURABOLIN	nandrolone decanoate	INJECTABLE;INJECTION	013132-002	Jun 12, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Woodward Specl	DECA-DURABOLIN	nandrolone decanoate	INJECTABLE;INJECTION	013132-001	Jun 12, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Woodward	FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	fluconazole	INJECTABLE;INJECTION	077909-003	Apr 20, 2015		RX	No	No		⤷ Subscribe				⤷ Subscribe
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-004	May 25, 1999		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Woodward

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-003	May 25, 1999	6,288,095*PED	⤷ Subscribe
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-004	May 25, 1999	6,288,095*PED	⤷ Subscribe
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-002	May 25, 1999	5,741,803*PED	⤷ Subscribe
Woodward	AVANDIA	rosiglitazone maleate	TABLET;ORAL	021071-003	May 25, 1999	5,741,803*PED	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for WOODWARD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Capsules	1 g	➤ Subscribe	2008-11-10

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.